Financial reports
NT 20-F
Notice of late annual filing (foreign)
2 Apr 24
20-F/A
2023 FY
Annual report (foreign) (amended)
6 Feb 24
20-F
2023 FY
Annual report (foreign)
14 Jun 23
20-F/A
2021 FY
Annual report (foreign) (amended)
6 May 22
20-F
2021 FY
Annual report (foreign)
1 Apr 22
20-F
2020 FY
Annual report (foreign)
31 Mar 21
20-F
2019 FY
Annual report (foreign)
30 Mar 20
20-F/A
2018 FY
Annual report (foreign) (amended)
4 Mar 19
20-F
2018 FY
Annual report (foreign)
28 Feb 19
20-F
2017 FY
Annual report (foreign)
1 Mar 18
Current reports
6-K
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
13 Mar 24
6-K
Intellipharmaceutics Announces Cease Trade Order
7 Mar 24
6-K
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
26 Feb 24
6-K
Intellipharmaceutics International Inc. Announces Stock Option Grant
9 Feb 24
6-K
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
11 Jan 24
6-K
Current report (foreign)
16 Oct 23
6-K
Annual Meeting of Shareholders
6 Oct 23
6-K
Intellipharmaceutics Reports Director Election Results
6 Oct 23
6-K
Current report (foreign)
26 Sep 23
6-K
Current report (foreign)
26 Sep 23
Registration and prospectus
424B3
Prospectus supplement
7 Jan 20
424B3
Prospectus supplement
7 Jan 20
25-NSE
Exchange delisting
3 Jun 19
424B3
Prospectus supplement
29 May 19
424B3
Prospectus supplement
29 May 19
424B3
Prospectus supplement
10 May 19
424B3
Prospectus supplement
10 May 19
424B3
Prospectus supplement
26 Apr 19
424B3
Prospectus supplement
26 Apr 19
424B3
Prospectus supplement
17 Apr 19
Proxies
No filings
Other
UPLOAD
Letter from SEC
14 Feb 24
EFFECT
Notice of effectiveness
12 Oct 18
CORRESP
Correspondence with SEC
11 Oct 18
CORRESP
Correspondence with SEC
11 Oct 18
UPLOAD
Letter from SEC
1 Oct 18
EFFECT
Notice of effectiveness
9 Aug 18
CORRESP
Correspondence with SEC
7 Aug 18
UPLOAD
Letter from SEC
23 Jul 18
EFFECT
Notice of effectiveness
17 Jul 17
CORRESP
Correspondence with SEC
14 Jul 17
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
SC 13G/A
ARMISTICE CAPITAL, LLC
15 Feb 22
SC 13G
ARMISTICE CAPITAL, LLC
16 Feb 21
SC 13G/A
Intellipharmaceutics International Inc.
11 Feb 20
SC 13G/A
Intellipharmaceutics International Inc.
21 Jan 20
SC 13D/A
Intellipharmaceutics International Inc.
18 Nov 19
SC 13G/A
Intellipharmaceutics International Inc.
14 Feb 19
SC 13G/A
Intellipharmaceutics International Inc.
14 Feb 19
SC 13G/A
Intellipharmaceutics International Inc.
1 Feb 19